Lakeshore Biopharma (NASDAQ:LSB – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Monday, January 27th. Analysts expect the company to announce earnings of ($0.80) per share for the quarter.
Lakeshore Biopharma Price Performance
LSB opened at $2.63 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.17 and a quick ratio of 0.90. Lakeshore Biopharma has a 12 month low of $1.88 and a 12 month high of $11.20. The business has a 50 day simple moving average of $2.86 and a 200-day simple moving average of $3.92.
About Lakeshore Biopharma
Further Reading
- Five stocks we like better than Lakeshore Biopharma
- Stock Analyst Ratings and Canadian Analyst Ratings
- Bloom Energy: Powering the Future With Decentralized Energy
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Lakeshore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeshore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.